As we noticed, most of the anti-obesity gene therapy approaches exploit the possibility of inducing white-to-beige adipose transition by overexpressing the genes coding for secreted factors, such as leptin, FGF21, or BMP7. The gene discussed is BMP7; the disease is obesity due to melanocortin 4 receptor deficiency.